← Leaderboards
Federico Gonzalez-Fernandez
University Of Virginia Charlottesville
$2,525,307
Attributed
$3,307,489
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $452K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,307,489 · 2
VA$0 · 1
By mechanism
R01$2,984,885 · 1
R24$322,604 · 1
I01$0 · 1
Top collaborators
- Debashis Ghosh4 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Larry C Borish$12,170,802
- Thomas J Braciale$22,435,148
- Jeffrey T Corwin$12,758,460
Others in their field
Top investigators on “Protein Structure Function”
- Andrzej Joachimiak Joachimiak · University Of Chicago$118,068,363
- Ian A Wilson · Scripps Research Institute, The$94,223,471
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Michael W Weiner · Northern California Institute Res &Educ$81,038,279
- Stephen K Burley · Rutgers University New Brunswick$74,994,995
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$73,742,932
Research focus
Protein Structure FunctionXenopusLigandsRetinoidsProtein BindingX Ray CrystallographyBinding SitesVisual PhotoreceptorRetinal Pigment EpitheliumConformationRetinoid Binding ProteinsAttenuatedAmino AcidsBaseArachidonic AcidsArachidonate 5-Lipoxygenase11 Cis RetinalChronic Neuropathic PainCattleAntioxidants11-Cis-RetinolCelecoxibCellsAdult
Grant awards (20)
Translational development of FDA-approved COX and LOX inhibitors to treat spinal cord injury-induced neuropathic pain.$0
I01 · FY2022 · VA · contact PI
Translational development of FDA-approved COX and LOX inhibitors to treat spinal cord injury-induced neuropathic pain.$0
I01 · FY2021 · VA · contact PI
Translational development of FDA-approved COX and LOX inhibitors to treat spinal cord injury-induced neuropathic pain.$0
I01 · FY2020 · VA · contact PI
Translational development of FDA-approved COX and LOX inhibitors to treat spinal cord injury-induced neuropathic pain.$0
I01 · FY2019 · VA · contact PI
Interphotoreceptor Retinoid Binding Protein: Structure and Function$378,621
R01 · FY2011 · EY · contact PI
Interphotoreceptor Retinoid Binding Protein: Structure and Function$390,452
R01 · FY2010 · EY · contact PI
Interphotoreceptor Retinoid Binding Protein: Structure and Function$394,396
R01 · FY2009 · EY · contact PI
MODULE--TRANSGENIC ANIMALS$53,531
R24 · FY2009 · EY · contact PI
Interphotoreceptor Retinoid Binding Protein: Structure and Function$400,896
R01 · FY2008 · EY · contact PI
MODULE--TRANSGENIC ANIMALS$51,065
R24 · FY2008 · EY · contact PI
MODULE--TRANSGENIC ANIMALS$49,006
R24 · FY2007 · EY · contact PI
IRBP: Structure and Function$218,904
R01 · FY2006 · EY · contact PI
MODULE--TRANSGENIC ANIMALS$47,677
R24 · FY2006 · EY · contact PI
IRBP: Structure and Function$224,257
R01 · FY2005 · EY
MODULE--TRANSGENIC ANIMALS$121,325
R24 · FY2005 · EY
IRBP: Structure and Function$225,325
R01 · FY2004 · EY
IRBP: Structure and Function$228,300
R01 · FY2003 · EY
IRBP--STRUCTURE/FUNCTION$176,561
R01 · FY2002 · EY
IRBP--STRUCTURE/FUNCTION$168,469
R01 · FY2001 · EY
IRBP--STRUCTURE/FUNCTION$178,704
R01 · FY2000 · EY